Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

As India grapples with a growing burden of diabetes and lifestyle-related disorders, attention has turned to Ozempic, a ...

Weight loss drug Ozempic has caused quite a stir this year, with many linking it to drastic celebrity weight loss. While ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral GLP-1 pill being studied for the treatment of type 2 diabetes and obesity, ...

An experimental new medication claims to help people lose weight without muscle loss. Here’s what you need to know about the ...

Berberine is an alkaloid compound found in plants with over 400-500 species. It has recently become popular as a potential ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.